Kim KI - Search Results

1

Clinical and genetic factors affecting tacrolimus trough levels and drug-related outcomes in Korean kidney transplant recipients.

Kim IW, Moon YJ, Ji E, Kim KI, Han N, Kim SJ, Shin WG, Ha J, Yoon JH, Lee HS, Oh JM. Kim IW, et al. Among authors: kim sj, kim ki. Eur J Clin Pharmacol. 2012 May;68(5):657-69. doi: 10.1007/s00228-011-1182-5. Epub 2011 Dec 20. Eur J Clin Pharmacol. 2012. PMID: 22183771

2

Low-dose botulinum toxin type A for the treatment of refractory piriformis syndrome.

Yoon SJ, Ho J, Kang HY, Lee SH, Kim KI, Shin WG, Oh JM. Yoon SJ, et al. Among authors: kim ki. Pharmacotherapy. 2007 May;27(5):657-65. doi: 10.1592/phco.27.5.657. Pharmacotherapy. 2007. PMID: 17461700 Clinical Trial.

3

Molecular characterization and prognostic significance of FLT3 in CML progression.

Kim KI, Park J, Ahn KS, Won NH, Kim BK, Shin WG, Yoon SS, Oh JM. Kim KI, et al. Among authors: kim bk. Leuk Res. 2010 Aug;34(8):995-1001. doi: 10.1016/j.leukres.2009.11.008. Epub 2009 Dec 23. Leuk Res. 2010. PMID: 20031210

4

Establishment of a new Glivec-resistant chronic myeloid leukemia cell line, SNUCML-02, using an in vivo model.

Park J, Kim KI, Koh Y, Won NH, Oh JM, Lee DS, Kim BK, Ahn KS, Yoon SS. Park J, et al. Among authors: kim bk, kim ki. Exp Hematol. 2010 Sep;38(9):773-81. doi: 10.1016/j.exphem.2010.04.012. Epub 2010 May 21. Exp Hematol. 2010. PMID: 20438801

5

Psychological distress as a negative survival factor for patients with hematologic malignancies who underwent allogeneic hematopoietic stem cell transplantation.

Park JE, Kim KI, Yoon SS, Hahm BJ, Lee SM, Yoon JH, Shin WG, Lee HS, Oh JM. Park JE, et al. Among authors: kim ki. Pharmacotherapy. 2010 Dec;30(12):1239-46. doi: 10.1592/phco.30.12.1239. Pharmacotherapy. 2010. PMID: 21114391

6

Population pharmacokinetics of cyclosporine in Korean adults undergoing living-donor kidney transplantation.

Ji E, Kim MY, Yun HY, Kim KI, Kang W, Kwon KI, Kim IW, Lee HS, Shin WG, Oh JM. Ji E, et al. Among authors: kim my, kim ki, kim iw. Pharmacotherapy. 2011 Jun;31(6):574-84. doi: 10.1592/phco.31.6.574. Pharmacotherapy. 2011. PMID: 21923441

7

Copy number variations in normal karyotype acute myeloid leukaemia and their association with treatment response.

Kim KI, Kim TK, Kim IW, Ahn KS, Yoon SS, Shin WG, Oh JM. Kim KI, et al. Among authors: kim tk, kim iw. Basic Clin Pharmacol Toxicol. 2012 Nov;111(5):317-24. doi: 10.1111/j.1742-7843.2012.00904.x. Epub 2012 Jun 29. Basic Clin Pharmacol Toxicol. 2012. PMID: 22672209 Free article.

8

Ethnic variability in the allelic distribution of pharmacogenes between Korean and other populations.

Kim IW, Kim KI, Chang HJ, Yeon B, Bang SJ, Park T, Kwon JS, Kim S, Oh JM. Kim IW, et al. Among authors: kim s, kim ki. Pharmacogenet Genomics. 2012 Dec;22(12):829-36. doi: 10.1097/FPC.0b013e328358dd70. Pharmacogenet Genomics. 2012. PMID: 22955668

9

Combined interaction of multi-locus genetic polymorphisms in cytarabine arabinoside metabolic pathway on clinical outcomes in adult acute myeloid leukaemia (AML) patients.

Kim KI, Huh IS, Kim IW, Park T, Ahn KS, Yoon SS, Yoon JH, Oh JM. Kim KI, et al. Among authors: kim iw. Eur J Cancer. 2013 Jan;49(2):403-10. doi: 10.1016/j.ejca.2012.07.022. Epub 2012 Sep 7. Eur J Cancer. 2013. PMID: 22964418

10

Unbalanced sample size effect on genome-wide population differentiation studies.

Han K, Kim KZ, Oh JM, Kim IW, Kim K, Park T. Han K, et al. Int J Data Min Bioinform. 2012;6(5):490-504. doi: 10.1504/ijdmb.2012.049303. Int J Data Min Bioinform. 2012. PMID: 23155778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,829 results

Search Page

Filters